Grenville Machado
Family Medicine · Copley, OHNPI 1861476608
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 606 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $4,082 and has fallen 90.9% since, to $373 in 2025. Among family medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 606 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$1K
- Amgen$1K
- Lilly USA, LLC$1K
- GSK$1K
- Boehringer Ingelheim$779
- plus $5K from 22 others
What the payments were for
- Food & beverage$12,004100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 90 | $1,500 |
| AstraZeneca | 45 | $1,330 |
| Amgen | 55 | $1,204 |
| Lilly USA, LLC | 68 | $1,154 |
| GSK | 58 | $1,076 |
| Boehringer Ingelheim | 48 | $779 |
| Pfizer | 50 | $729 |
| Biohaven Pharmaceuticals, Inc. | 18 | $681 |
| Phathom Pharmaceuticals, Inc. | 4 | $485 |
| Johnson & Johnson | 19 | $485 |
| Amarin Pharma, Inc. | 27 | $445 |
| Teva Pharmaceuticals USA, Inc. | 17 | $272 |
| Novo Nordisk | 24 | $269 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $227 |
| Kowa Pharmaceuticals America, Inc. | 16 | $220 |
| Esperion Therapeutics, Inc. | 8 | $212 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $202 |
| Bayer | 5 | $182 |
| Abbott | 10 | $159 |
| E.r. Squibb & Sons, L.L.C. | 7 | $99 |
| Merck | 7 | $98 |
| Novartis | 5 | $82 |
| Jazz Pharmaceuticals Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Eisai Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Genentech USA, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,016 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Copley
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.